A5005295554- Urologic and reproductive health conditions
- Bladder and Urothelial Cancer Treatments
- Heat shock proteins research
- Inflammatory Biomarkers in Disease Prognosis
- Prostate Cancer Treatment and Research
- Radiopharmaceutical Chemistry and Applications
- Cancer, Lipids, and Metabolism
- Lung Cancer Treatments and Mutations
- HER2/EGFR in Cancer Research
Jiangnan University
2024
Wenzhou Medical University
2022-2023
First Affiliated Hospital of Wenzhou Medical University
2022-2023
The combination of hemoglobin, albumin, lymphocyte, and platelet (HALP) score has been confirmed as an important risk biomarker in several cancers. Hence, we aimed at evaluating the prognostic value HALP patients with non-metastatic upper tract urothelial carcinoma (UTUC). We retrospectively enrolled 533 640 from two centers (315 325 patients, respectively) who underwent radical nephroureterectomy (RNU) for UTUC this study. cutoff was determined using Youden index by performing receiver...
Prostate cancer (PCa) is one of the most common malignant tumors male urogenital system; however, underlying mechanisms remain largely unclear. This study integrated two cohort profile datasets to elucidate potential hub genes and in PCa.Gene expression profiles GSE55945 GSE6919 were filtered from Gene Expression Omnibus (GEO) database obtain 134 differentially expressed (DEGs) (14 upregulated 120 downregulated) PCa. Ontology pathway enrichment performed using Database for Annotation,...
Background The human epidermal growth factor receptor 2 gene (HER2) has been identified as a potential therapeutic target in lung adenocarcinoma (LUAD). Non-invasive positron emission tomography (PET) imaging provides reliable strategy for vivo determination of HER2 expression through whole-body detection abnormalities. PET tracer 68 Ga-NOTA-MAL-Cys-MZHER 2:342 shown promising results HER2-positive breast and gastric cancers. This study aims to evaluate the performance vitro models clinical...